Brief: Daewoong Pharmaceutical Announces Success In Developing A New Antidiabetic Medication
06/12/2022 12:50
Dec 6 (Reuters) - Daewoong Pharma 069620.KS :
* DAEWOONG PHARMACEUTICAL ANNOUNCES SUCCESS IN DEVELOPING A
NEW
ANTIDIABETIC MEDICATION AND ITS AIMS TO ENTER THE MARKET IN OVER
50 COUNTRIES BY 2030
* DAEWOONG PHARMA- ANNOUNCED ON 5TH DEC, ITS "ENVLO 0.3MG"
OBTAINED PRODUCT LICENSE FROM MINISTRY OF FOOD AND DRUG SAFETY
ON NOV 30
Source text for Eikon: ID:nPn9GvdXSa
Further company coverage: 069620.KS
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier